| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| XOMA Corp | SVP, Finance & CFO | Performance Stock Units | 91.6K | $1.27M | $13.89 | May 18, 2023 | Direct |
| Acorda Therapeutics, Inc. | Director | Non-Employee Stock Option | 2.4K | Jun 22, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ACOR | Acorda Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| ACOR | Acorda Therapeutics, Inc. | Jun 22, 2023 | 0 | $0 | 3 | Jun 23, 2023 | Director |
| XOMA | XOMA Corp | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | SVP, Finance & CFO |
| XOMA | XOMA Corp | Nov 8, 2022 | 1 | $0 | 4 | Nov 9, 2022 | SVP, Finance & CFO |
| XOMA | XOMA Corp | Jul 15, 2022 | 3 | -$55.3K | 4 | Jul 18, 2022 | SVP, Finance & CFO |
| XOMA | XOMA Corp | Mar 21, 2022 | 9 | -$365K | 4 | Mar 23, 2022 | SVP, Finance & CFO |
| XOMA | XOMA Corp | Feb 22, 2022 | 1 | $0 | 4 | Feb 23, 2022 | SVP, Finance & CFO |